Octagon Capital Advisors »

Aktis Oncology shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Aktis Oncology shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Aktis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Aktis Oncology held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aktis Oncology by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $17M 961k 17.89

More positions owned by Octagon Capital Advisors

Dianthus Therapeutics (DNTH)
Cogent Biosciences (COGT)
Abivax Sa Sponsored Ads (ABVX)
Alumis (ALMS)
Definium Therapeutics Com Shs (DFTX)
Arrivent Biopharma (AVBP)
Taysha Gene Therapies Com Shs (TSHA)
Kymera Therapeutics (KYMR)
Mirum Pharmaceuticals (MIRM)
Bioage Labs (BIOA)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Kalvista Pharmaceuticals (KALV)
Xenon Pharmaceuticals (XENE)
Terns Pharmaceuticals (TERN)
Ocular Therapeutix (OCUL)

View all positions for Octagon Capital Advisors

Top funds holding Aktis Oncology

MPM Oncology Impact Management
EcoR1 Capital
BlackRock
RA Capital Management
Henderson Group
Baker Bros. Advisors
Octagon Capital Advisors
Merck & Co
Vanguard Capital Management
Geode Capital Management
Avidity Partners Management
AH Capital Management
UBS Group
Arrowpoint Asset Management
Alyeska Investment Group

View all funds holding Aktis Oncology